Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$31.2 0.32%
Market Cap
$2.2B
Price Target
Refer to Report
Volume
247.2K
52wk Range
$20.65 - $43.25
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.